Correlation Between Acrivon Therapeutics, and Amylyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Acrivon Therapeutics, and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Amylyx Pharmaceuticals.
Diversification Opportunities for Acrivon Therapeutics, and Amylyx Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Acrivon and Amylyx is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Amylyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Amylyx Pharmaceuticals
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to under-perform the Amylyx Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Acrivon Therapeutics, Common is 1.26 times less risky than Amylyx Pharmaceuticals. The stock trades about -0.08 of its potential returns per unit of risk. The Amylyx Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 533.00 in Amylyx Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 12.00 from holding Amylyx Pharmaceuticals or generate 2.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Amylyx Pharmaceuticals
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Amylyx Pharmaceuticals |
Acrivon Therapeutics, and Amylyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Amylyx Pharmaceuticals
The main advantage of trading using opposite Acrivon Therapeutics, and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.| Acrivon Therapeutics, vs. Bright Minds Biosciences | Acrivon Therapeutics, vs. HP Inc | Acrivon Therapeutics, vs. Intel | Acrivon Therapeutics, vs. Chevron Corp |
| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |